Natriuretic peptide receptor a signaling regulates stem cell recruitment and angiogenesis: A model to study linkage between inflammation and Tumorigenesis

Stem Cells

Volumn 31, Issue 7, 2013, Pages 1321-1329

  Mallela, Jaya ^a,b   Ravi, Sowndharya ^a,b   Louis, Frantz Jean ^a,b   Mulaney, Bianca ^a   Cheung, Michael ^a,b   Garapati, Ujjwala Sree ^a,b   Chinnasamy, Vignesh ^a,b   Wang, Chunyan ^a,b   Nagaraj, Srinivas ^a,b   Mohapatra, Shyam S ^a,b   Mohapatra, Subhra ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Nanomedicine Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; LIPOPOLYSACCHARIDE; NATRIURETIC PEPTIDE RECEPTOR A; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INFLAMMATION; LUNG CARCINOMA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOGENESIS; CARCINOMA, LEWIS LUNG; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR MICROENVIRONMENT;

MUS;

EID: 84879962331     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1376     Document Type: Article

References (54)

1. Kong X, Wang X, Xu W et al. Natriuretic peptide receptor a as a novel anticancer target. Cancer Res 2008;68:249-256.
2. Wang X, Raulji P, Mohapatra SS et al. Natriuretic peptide receptor a as a novel target for prostate cancer. Mol Cancer 2011;10:56.
3. Airhart N, Yang YF, Roberts CT et al. Atrial natriuretic peptide induces natriuretic peptide receptor-cGMP-dependent protein kinase interaction. J Biol Chem 2003;278:38693-38698.
4. Chen H, Levine YC, Golan DE et al. Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium. J Biol Chem 2008;283:4439-4447.
5. Margheri F, Serrati S, Lapucci A et al. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gainloss of function of pentraxin 3 and matrix metalloproteinase 12. Arthritis Rheum 2010;62:2488-2498.
6. Trabocchi A, Menchi G, Cini N et al. Click-chemistry-derived triazole ligands of arginine-glycine-aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis. J Med Chem 2010;53:7119-7128.
7. Franco M, Roswall P, Cortez E et al. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 2011;118:2906-2917.
8. Kerbel RS. Reappraising antiangiogenic therapy for breast cancer. Breast 2011;20(suppl 3):S56-S60.
9. Aokage K, Ishii G, Ohtaki Y et al. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal- epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2011;128:1585-1595.
10. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008;358:2039-2049.
11. Kim KJ, Li B, Winer J et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-844.
12. Ebos JM, Kerbel RS. Antiangiogenic therapy: Impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 2011;8:210-221.
13. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005;15:97-101.
14. Ebos JM, Lee CR, Kerbel RS. Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin Cancer Res 2009;15:5020-5025.
15. Kerbel RS. Antiangiogenic therapy: A universal chemosensitization strategy for cancer? Science 2006;312:1171-1175.
16. Olson P, Chu GC, Perry SR et al. Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma. Proc Natl Acad Sci USA 2011;108:E1275-1284.
17. Pere H, Montier Y, Bayry J et al. A CCR4 antagonist combined with vaccines induces antigen-specific CD8 T cells and tumor immunity against self antigens. Blood 2011;118:4853-4862.
18. Bellacen K, Lewis EC. Aortic ring assay. J Vis Exp 2009:e1564.
19. Falcon BL, Pietras K, Chou J et al. Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor- B. Am J Pathol 2011;178:2920-2930.
20. Xie L, Duncan MB, Pahler J et al. Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. Proc Natl Acad Sci USA 2011;108:9939-9944.
21. Sodir NM, Swigart LB, Karnezis AN et al. Endogenous Myc maintains the tumor microenvironment. Genes Dev 2011;25:907-916.
22. Collisson EA, Sadanandam A, Olson P et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 2011;17:500-503.
23. Spaeth EL, Dembinski JL, Sasser AK et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. Plos One 2009;4:e4992.
24. Lin EH, Jiang Y, Deng Y et al. Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: ''seed and soil'' theory revisited. Gastrointest Cancer Res 2008;2:169-174.
25. Kandasamy R, Park SJ, Boyapalle S et al. Isatin down-regulates expression of atrial natriuretic peptide receptor A and inhibits airway inflammation in a mouse model of allergic asthma. Int Immunopharmacol 2010;10:218-225.
26. Mohapatra SS. Role of natriuretic peptide signaling in modulating asthma and inflammation. Can J Physiol Pharmacol 2007;85:754-759.
27. Wang X, Xu W, Mohapatra S et al. Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet Vaccines Ther 2008;6:7.
28. Wang X, Xu W, Kong X et al. Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respir Res 2009;10:66.
29. Tuveson D, Hanahan D. Translational medicine: Cancer lessons from mice to humans. Nature 2011;471:316-317.
30. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
31. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 2003;107:1448-1453.
32. Kuhn M, Volker K, Schwarz K et al. The natriuretic peptide/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice. J Clin Invest 2009;119:2019-2030.
33. Muehlberg FL, Song YH, Krohn A et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009;30: 589-597.
34. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-563.
35. Galie M, Konstantinidou G, Peroni D et al. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene 2008;27:2542-2551.
36. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837-3844.
37. Djouad F, Fritz V, Apparailly F et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005;52:1595-1603.
38. Kucerova L, Matuskova M, Pastorakova A et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med 2008;10:1071-1082.
39. Coffelt SB, Marini FC, Watson K et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 2009;106:3806-3811.
40. Lin G, Yang R, Banie L et al. Effects of transplantation of adipose tissuederived stem cells on prostate tumor. The Prostate 2010;70:1066-1073.
41. Prantl L, Muehlberg F, Navone NM et al. Adipose tissue-derived stem cells promote prostate tumor growth. The Prostate 2010;70:1709-1715.
42. Zhu W, Xu W, Jiang R et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006; 80:267-274.
43. Shinagawa K, Kitadai Y, Tanaka M et al. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer 2010; 127:2323-2333.
44. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-674.
45. Muramatsu F, Kidoya H, Naito H et al. microRNA-125b inhibits tube formation of blood vessels through translational suppression of VEcadherin. Oncogene 2013;32:414-421.
46. Beckermann BM, Kallifatidis G, Groth A et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 2008;99:622-631.
47. Yuan L, Wu MJ, Sun HY et al. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin- induced acute kidney injury. Am J Physiol Renal Physiol 2011; 300:F207-F218.
48. Kryczek I, Lange A, Mottram P et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 2005;65:465-472.
49. Akimoto K, Kimura K, Nagano M et al. Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote glioblastoma multiforme proliferation. Stem Cells Dev 2013 [Epub Ahead of Print].
50. Wang L, Chang EW, Wong SC et al. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 2013;190:794-804.
51. Jayaraman P, Parikh F, Lopez-Rivera E et al. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloidderived suppressor cells through modulation of vascular endothelial growth factor release. J Immunol 2012;188:5365-5376.
52. Obermajer N, Muthuswamy R, Odunsi K, et al. PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res 2011; 71:7463-7470.
53. Sakimoto S, Kidoya H, Naito H et al. A role for endothelial cells in promoting the maturation of astrocytes through the apelin/APJ system in mice. Development 2012;139:1327-1335.
54. Naito H, Takara K, Wakabayashi T et al. Changes in blood vessel maturation in the fibrous cap of the tumor rim. Cancer Sci 2012;103: 433-438.